Physician profile
Doreen Ng
NPI 1376772848
$1,500.87
in general payments reported to CMS, 2019-2025
10 companies · $74.04 in 2025
The $74.04 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $44.85 · 2021: $216 · 2022: $700 · 2023: $124 · 2024: $342 · 2025: $74.04.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $540.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $540.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $330.00 | 2022-2024 | Acuvue |
| Glaukos Corporation | $239.47 | 2022-2024 | |
| Alcon Vision LLC | $193.50 | 2022-2025 | Total30, Precision7 |
| Sight Sciences, INC. | $179.97 | 2021-2022 | |
| Coopervision INC. | $153.83 | 2021-2025 | Myday Contact Lens, Clariti Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $149.59 | 2020-2021 | |
| Abbvie INC. | $115.05 | 2022 | |
| Bausch & Lomb Americas INC. | $90.71 | 2022-2024 | Infuse |
| Biotissue Holdings INC. | $28.49 | 2025 | |
| Allergan, INC. | $20.26 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Doreen Ng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.